Munich - Delayed Quote EUR
ChromaDex Corp (OCD1.MU)
6.20
+0.20
+(3.33%)
As of 8:08:08 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
99,597
99,597
83,570
72,050
67,449
Cost of Revenue
38,011
38,011
32,790
29,253
25,959
Gross Profit
61,586
61,586
50,780
42,797
41,490
Operating Expense
53,860
53,860
56,379
61,425
68,563
Operating Income
7,726
7,726
-5,599
-18,628
-27,073
Net Non Operating Interest Income Expense
1,129
1,129
661
3
-55
Other Income Expense
--
--
--
2,085
--
Pretax Income
8,855
8,855
-4,938
-16,540
-27,128
Tax Provision
305
305
--
--
--
Net Income Common Stockholders
8,550
8,550
-4,938
-16,540
-27,128
Diluted NI Available to Com Stockholders
8,550
8,550
-4,938
-16,540
-27,128
Basic EPS
0.11
0.11
-0.07
-0.24
-0.40
Diluted EPS
0.11
0.11
-0.07
-0.24
-0.40
Basic Average Shares
75,929
75,929
74,985
69,729
67,185
Diluted Average Shares
78,125
78,125
74,985
69,729
67,185
Total Operating Income as Reported
7,726
7,726
-5,599
-18,628
-27,073
Total Expenses
91,871
91,871
89,169
90,678
94,522
Net Income from Continuing & Discontinued Operation
8,550
8,550
-4,938
-16,540
-27,128
Normalized Income
8,550
8,550
-4,938
-16,540
-27,128
Interest Income
1,129
1,129
661
3
--
Net Interest Income
1,129
1,129
661
3
-55
EBIT
7,726
7,726
-5,599
-18,628
-27,073
EBITDA
9,210
9,210
-3,894
-16,744
-25,447
Reconciled Cost of Revenue
38,011
38,011
32,790
29,253
25,959
Reconciled Depreciation
1,484
1,484
1,705
1,884
1,626
Net Income from Continuing Operation Net Minority Interest
8,550
8,550
-4,938
-16,540
-27,128
Normalized EBITDA
9,210
9,210
-3,894
-16,744
-25,447
Tax Rate for Calcs
0
0
--
--
--
12/31/2021 - 3/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
NXOA.BE Nicox SA
0.2275
+0.66%
0M4.DU Mersana Therapeutics Inc
0.3383
+0.06%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
GON.DU Geron Corp
1.2350
+0.90%
300759.SZ Pharmaron Beijing Co., Ltd.
23.08
+1.58%
50BA.F Bicycle Therapeutics plc
6.75
-11.18%
PI3.DU Gubra AS
46.80
-2.94%